Cell Culture Technology– category –
-
SuperMeat Secures $6M in Funding, Accelerating Commercialization of Cultivated Chicken for Swiss Market Entry
PPTI News - Protein Production Technology International UK Overview SuperMeat has raised $6 million in Series A-4 funding, part of a targeted $10 million round, to accelerate the commercialization of its cultivated chicken technology and... -
ProBio and Curocell Achieve BLA Approval for Next-Gen CD19-Targeted CAR-T Therapy, Initiating Commercial Production in South Korea
ProBio CDMO South Korea Overview ProBio CDMO and Curocell have secured Biologics License Application (BLA) approval for anbalcabtagene autoleucel (Anbal-cel; CRC01), their next-generation CD19-targeted CAR-T cell therapy for relapsed or ... -
AIST Develops Novel Culture Media Analysis Technology Using Multifluorescent Polymers and AI, Revolutionizing Biomanufacturing Quality Control
AFPBB News Japan Overview Japan's National Institute of Advanced Industrial Science and Technology (AIST) has developed a novel analytical technology to assess the quality of cell culture media and supplements, critical for biomanufactur... -
Terumo BCT and Steminent Partner to Automate Mesenchymal Stem Cell Manufacturing for Late-Stage Clinical Commercialization
Terumo Blood and Cell Technologies Taiwan Overview Terumo Blood and Cell Technologies (Terumo BCT) and Taipei-based Steminent Biotherapeutics Inc. have announced a strategic collaboration to accelerate late-stage manufacturing readiness ... -
Ajinomoto Develops Novel Culture Medium Supplement to Boost Gene Therapy Drug Productivity, Accelerating Biomanufacturing Efficiency
味の素株式会社 IRニュース Japan Overview Ajinomoto Group, in collaboration with its U.S. subsidiary Forge Biologics (acquired in 2023 for ~¥82.8 billion), has developed a novel culture medium supplement designed to significantly enhance ... -
Helios Advances ARDS Therapy Approval, Bolstering Regenerative Medicine CDMO with New Kobe Manufacturing Hub
FISCO Japan Overview Helios is progressing towards regulatory approval for its Acute Respiratory Distress Syndrome (ARDS) therapeutic, HLCM051, while simultaneously enhancing its Contract Development and Manufacturing Organization (CDMO)... -
South Korea Approves First ‘Pre-Approval Therapy’ Plan for Advanced Regenerative Medicine, Significantly Broadening Patient Access
Newsweek Japan South Korea Overview South Korea's government has approved its inaugural advanced regenerative medical treatment plan under a groundbreaking 'pre-approval therapy' framework, allowing critically ill patients access to cutt... -
BIOSECURE Act Reshapes Biopharma Supply Chains, Driving API and Oligo CDMO Expansion in South Korea
CHOSUNBIZ South Korea Overview The U.S. BIOSECURE Act is catalyzing a significant shift in biopharmaceutical supply chains away from China, creating substantial opportunities for South Korean contract development and manufacturing organi... -
CellFiber and Locus Cell Establish Commercial-Scale Manufacturing for Human Umbilical Cord-Derived Mesenchymal Stem Cells Using Advanced 3D Culture Technology
PR TIMES Japan Overview Japan's CellFiber and its Taiwanese partner Locus Cell have successfully established a commercial-scale manufacturing process for human umbilical cord-derived mesenchymal stem cells (UC-MSC) utilizing the innovati... -
South Korean Biotech Giants Diverge: Samsung Biologics Faces Labor Risks Amid Record Growth, Celltrion Boosts Global CDMO Expansion
aju press South Korea Overview South Korea's leading biotech firms, Samsung Biologics and Celltrion, show divergent paths: Samsung Biologics achieved record Q1 2026 performance with 25.8% revenue growth due to full plant utilization but ...
